We then performed gene ontology (GO) analysis on the differentially methylated enhancers and found significant enrichment in signaling pathways commonly affected in liver cancer, including regulation of RAC1 activity (29) and interleukin-8 (IL-8)– and CXCR1-mediated signaling (fig. This evidence concerns the gene CXCL8 and liver cancer.